A simultaneous presentation of drug-induced lupus with drug-induced ANCA vasculitis secondary to hydralazine use in a patient with sarcoidosis. Issue 2 (3rd April 2019)

• Record Type: Journal Article
• Authors: Espinosa, Maria Catalina; Ding, Belicia; Choi, Kati; Cohen, Daniel N.; Marcelli, Marco; Ifoeze, Onome Whiteru
• Is Part Of: Proceedings. Volume 32:Issue 2(2019)
• Page Start: 231
• Page End: 234
• Publication Date: 2019-04-03
• Subjects: Drug-induced anti-neutrophil cytoplasmic antibody vasculitis -- drug-induced lupus -- hydralazine -- leukocytoclastic vasculitis; Medicine -- Periodicals; Medicine; Medicine -- Periodicals; Periodicals; Electronic journals; 616.005
• DOI: 10.1080/08998280.2019.1570422
• Languages: English
• ISSNs: 0899-8280

Abstract

Abstract: Frequently used in the management of hypertension and heart failure, hydralazine is associated with the development of adverse rheumatologic side effects. The authors highlight a unique case of drug-induced lupus and drug-induced anti-neutrophil cytoplasmic antibody (ANCA) vasculitis from hydralazine use in a 50-year-old man with sarcoidosis and hypertension.